Related references
Note: Only part of the references are listed.Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage
Hong-Tao Xu et al.
APMIS (2013)
MiR-93 enhances angiogenesis and metastasis by targeting LATS2
Ling Fang et al.
CELL CYCLE (2012)
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
Xin Fu et al.
FEBS LETTERS (2012)
miR-93/Sp7 function loop mediates osteoblast mineralization
Li Yang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
miR-145 is differentially regulated by TGF-ß1 and ischaemia and targets Disabled-2 expression and wnt/ß-catenin activity
Maritza E. Mayorga et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
miR-93/106b and Their Host Gene, MCM7, Are Differentially Expressed in Leiomyomas and Functionally Target F3 and IL-8
Tsai-Der Chuang et al.
MOLECULAR ENDOCRINOLOGY (2012)
Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2
A. Chao et al.
ONCOGENE (2012)
Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer
K. Kim et al.
ONCOGENE (2012)
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
A. L. Smith et al.
ONCOGENE (2012)
Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition
Joost Kluiver et al.
PLOS ONE (2012)
miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers
Liqin Du et al.
PLOS ONE (2012)
Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer
Tingting Wang et al.
PLOS ONE (2012)
Repression of human activation induced cytidine deaminase by miR-93 and miR-155
Glen M. Borchert et al.
BMC CANCER (2011)
Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancers
Hong-Tao Xu et al.
HUMAN PATHOLOGY (2011)
Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs
David M. Garcia et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
L. Fang et al.
ONCOGENE (2011)
Identification of MicroRNA-93 as a Novel Regulator of Vascular Endothelial Growth Factor in Hyperglycemic Conditions
Jianyin Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter
Adele Hannigan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
miR-221 overexpression contributes to liver tumorigenesis
Pascal Pineau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma
Yang Li et al.
CANCER SCIENCE (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1
Liqin Du et al.
MOLECULAR CANCER RESEARCH (2009)
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer
Young-Kook Kim et al.
NUCLEIC ACIDS RESEARCH (2009)
E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer
Fabio Petrocca et al.
CANCER CELL (2008)
Roles for MicroRNAs, miR-93 and miR-130b, and Tumor Protein 53-induced Nuclear Protein 1 Tumor Suppressor in Cell Growth Dysregulation by Human T-Cell Lymphotrophic Virus 1
Man Lung Yeung et al.
CANCER RESEARCH (2008)
Loss and reduction of Fus1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer
Ludmila Prudkin et al.
CLINICAL CANCER RESEARCH (2008)
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer
Sarangadhara Appala Raju Bagadi et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
Diego F. Calvisi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder
Jose A. Karam et al.
CLINICAL CANCER RESEARCH (2007)
MicroRNA targeting specificity in mammals: Determinants beyond seed pairing
Andrew Grimson et al.
MOLECULAR CELL (2007)
Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis
Kumar Anupam et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null background
Dong-Hua Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer
J Zhou et al.
CANCER RESEARCH (2005)
Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array
H Wikman et al.
ONCOGENE (2002)
Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation
JQ He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
